Yicheng Guo

2009–2026 年に発表

106
論文数
20,142
被引用数
52
h 指数
82
i10 指数

被引用数

Yicheng Guo の年別被引用数1982 年: 被引用 1 件2002 年: 被引用 1 件2009 年: 被引用 2 件2010 年: 被引用 9 件2011 年: 被引用 17 件2012 年: 被引用 68 件2013 年: 被引用 92 件2014 年: 被引用 132 件2015 年: 被引用 139 件2016 年: 被引用 119 件2017 年: 被引用 93 件2018 年: 被引用 70 件2019 年: 被引用 110 件2020 年: 被引用 124 件2021 年: 被引用 561 件2022 年: 被引用 668 件2023 年: 被引用 551 件2024 年: 被引用 740 件2025 年: 被引用 374 件2026 年: 被引用 15 件1983〜2001 年は被引用が無いため表示していません2003〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,306 件、この内訳の 22.6%中国: 引用元論文 732 件、この内訳の 12.7%イギリス: 引用元論文 484 件、この内訳の 8.4%ドイツ: 引用元論文 339 件、この内訳の 5.9%フランス: 引用元論文 284 件、この内訳の 4.9%イタリア: 引用元論文 205 件、この内訳の 3.6%オランダ: 引用元論文 187 件、この内訳の 3.2%カナダ: 引用元論文 155 件、この内訳の 2.7%スイス: 引用元論文 153 件、この内訳の 2.7%日本: 引用元論文 144 件、この内訳の 2.5%スペイン: 引用元論文 133 件、この内訳の 2.3%オーストラリア: 引用元論文 129 件、この内訳の 2.2%
0%22.6%その他 26.3%

分野

  • Medicine64.6%
  • Physics and Astronomy17.2%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Immunology and Microbiology3.6%
  • Computer Science2.9%
  • Pharmacology, Toxicology and Pharmaceutics1.5%
  • その他4.4%

トピック

  • SARS-CoV-2 and COVID-19 Research17.5%
  • COVID-19 Clinical Research Studies7.7%
  • Galaxies: Formation, Evolution, Phenomena5.8%
  • vaccines and immunoinformatics approaches4%
  • SARS-CoV-2 detection and testing3.5%
  • Astronomy and Astrophysical Research3.3%
  • その他58.2%

共著者

全論文

検索で開く
  1. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

    著者: , , , , , , , , , , , , , , , , - Cell 2022 被引用: 946

  2. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike

    著者: , , , , , , , , , , , , , , , , , , , , - Nature 2023 被引用: 206

  3. Down-Regulating Scar Formation by Microneedles Directly via a Mechanical Communication Pathway

    著者: , , , , , , , , , , , , , , - ACS Nano 2022 被引用: 192

  4. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1

    著者: , , , , , , , , - Cell Host & Microbe 2024 被引用: 177

  5. Antibody evasion properties of SARS-CoV-2 Omicron sublineages

    著者: , , , , , , , , , , , , , , , , , , - Nature 2022 被引用: 861

  6. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

    著者: , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2021 被引用: 587

  7. Snake extract–laden hemostatic bioadhesive gel cross-linked by visible light

    著者: , , , , , , , , , - Science Advances 2021 被引用: 179

  8. Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6

    著者: , , , , , , , , , - The Lancet Infectious Diseases 2023 被引用: 89

  9. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants

    著者: , , , , , , , , - 2023 被引用: 43

  10. Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages

    著者: , , , , , , , , , , , , , - Emerging Microbes & Infections 2024 被引用: 57

  11. Structures of LRP2 reveal a molecular machine for endocytosis

    著者: , , , , , , , , , , , , , , - Cell 2023 被引用: 72

  12. Interpretable Failure Localization for Microservice Systems Based on Graph Autoencoder

    著者: , , , , , , , , , - ACM Transactions on Software Engineering and Methodology, ACM Trans. Softw. Eng. Methodol. 2024 被引用: 18

  13. Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking

    著者: , , , , , , , , , , , , , , , , , , , - Immunity 2023 被引用: 32

  14. CANDELS: THE COSMIC ASSEMBLY NEAR-INFRARED DEEP EXTRAGALACTIC LEGACY SURVEY

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Dickinson, Timothy Dolch, J. L. Donley, J. S. Dunlop, Aaron A. Dutton, David Elbaz, G. G. Fazio, A. V. Filippenko, Steven L. Finkelstein, A. Fontana, Jonathan P. Gardner, P. Garnavich, Eric Gawiser, Mauro Giavalisco, A. Grazian, Yicheng Guo, Nimish P. Hathi, Boris Häußler, Philip F. Hopkins, Jia-Sheng Huang, Kuang-Han Huang, Saurabh W. Jha, Jeyhan S. Kartaltepe, R. Kirshner, David C. Koo, K. Lai, Kyoung-Soo Lee, Weidong Li, Jennifer M. Lotz, Ray A. Lucas, Piero Madau, Patrick J. McCarthy, Elizabeth J. McGrath, Daniel H. McIntosh, R. J. McLure, Bahram Mobasher, Leonidas A. Moustakas, Mark Mozena, K. Nandra, Jeffrey A. Newman, Sami-Matias Niemi, K. G. Noeske, Casey Papovich, L. Pentericci, Alexandra Pope, Joel R. Primack, Abhijith Rajan, Swara Ravindranath, Naveen A. Reddy, A. Renzini, Hans‐Walter Rix, Aday R. Robaina, S. Rodney, D. J. Rosario, P. Rosati, S. Salimbeni, Claudia Scarlata, Brian Siana, Luc Simard, Joseph Smidt, Rachel S. Somerville, Hyron Spinrad, Amber N. Straughn, Louis-Gregory Strolger, O. Grace Telford, Harry I. Teplitz, Jonathan R. Trump, Arjen van der Wel, C. Villforth, Risa H. Wechsler ほか 7 名 - The Astrophysical Journal Supplement Series 2011 被引用: 2,174

  15. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

    著者: , , , , , , , , , , , , , , , , , , - Cell 2022 被引用: 953

  16. Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation

    著者: , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2022 被引用: 82

  17. Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain

    著者: , , , , , , , , , , , , , , - Cell Reports 2021 被引用: 81

  18. An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David D. Ho - Science Translational Medicine 2022 被引用: 66

  19. CANDELS: THE COSMIC ASSEMBLY NEAR-INFRARED DEEP EXTRAGALACTIC LEGACY SURVEY—THE HUBBLE SPACE TELESCOPE OBSERVATIONS, IMAGING DATA PRODUCTS, AND MOSAICS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , O. Almaini, M. L. N. Ashby, M. Barden, Eric F. Bell, F. Bournaud, T. M. Brown, K. I. Caputi, P. Cassata, Peter Challis, Ranga‐Ram Chary, Edmond Cheung, Michele Cirasuolo, Christopher J. Conselice, Asantha Cooray, Darren Croton, E. Daddi, Romeel Davé, D. F. de Mello, Loïc de Ravel, Avishai Dekel, J. L. Donley, J. S. Dunlop, Aaron A. Dutton, David Elbaz, G. G. Fazio, A. V. Filippenko, Steven L. Finkelstein, Chris Frazer, Jonathan P. Gardner, P. Garnavich, Eric Gawiser, Ruth Gruetzbauch, W G Hartley, Boris Häußler, Jessica Herrington, Philip F. Hopkins, Jia-Sheng Huang, Saurabh W. Jha, Andrew Johnson, Jeyhan S. Kartaltepe, Ali Ahmad Khostovan, R. Kirshner, Caterina Lani, Kyoung-Soo Lee, Weidong Li, Piero Madau, Patrick J. McCarthy, Daniel H. McIntosh, R. J. McLure, Conor McPartland, Bahram Mobasher, Heidi Moreira, Alice Mortlock, Leonidas A. Moustakas, Mark Mozena, K. Nandra, Jeffrey A. Newman, Jennifer L. Nielsen, S.-M Niemi, K. G. Noeske, Casey Papovich, L. Pentericci, Alexandra Pope, Joel R. Primack, Swara Ravindranath, Naveen A. Reddy, A. Renzini, Hans‐Walter Rix, Aday R. Robaina, D. J. Rosario ほか 24 名 - The Astrophysical Journal Supplement Series 2011 被引用: 2,070

  20. Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages

    著者: , , , - New England Journal of Medicine 2024 被引用: 33

  21. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Harrison W. Farber, Robert P. Frantz, Jean Elwing, Nicholas S. Hill, D. Dunbar Ivy, James Klinger, Steven D. Nathan, Ronald J. Oudiz, Ivan M. Robbins, Robert Schilz, Terry Fortin, Jeffrey Wilt, Delphine Yung, Eric D. Austin, Ferhaan Ahmad, Nitin Bhatt, Tim Lahm, Adaani Frost, Zeenat Safdar, Zia Ur Rehman, Robert Walter, Fernando Torres, Sahil Bakshi, Stephen L. Archer, Rahul Argula, Christopher F. Barnett, Raymond L. Benza, Ankit A. Desai, Veeranna Maddipati, Harm Jan Bogaard, Colin Church, Gerry Coghlin, Robin Condliffe, Mélanie Eyries, Henning Gall, Stefano Ghio, Barbara Girerd, Simon Holden, Luke Howard, Marc Humbert, David G. Kiely, Gábor Kovács, Jim Lordan, Rajiv D. Machado, Robert V. MacKenzie Ross, Colm McCabe, Jennifer M. Martin, Shahin Moledina, David Montani, Horst Olschewski, Christopher J. Penkett, Joanna Pepke‐Żaba, Laura Price, Christopher J. Rhodes, Werner Seeger, Florent Soubrier, Laura Southgate, Jay Suntharalingam, Andrew J. Swift, Mark Toshner, Carmen Treacy, Anton Vonk Noordegraaf, John Wharton, Jim M. Wild, Stephen J. Wort, National Cohort Study of Idiopathic and Heritable PAH, Harm Jan Bogaard, Colin Church, Gerry Coghlin, Robin Condliffe ほか 37 名 - Genome Medicine 2021 被引用: 85

  22. Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2

    著者: , , , , , , , , , , , , - iScience 2023 被引用: 27

  23. Cryo-EM structure of the SARS-CoV-2 Omicron spike

    著者: , , , , , , , , , , - Cell Reports 2022 被引用: 114

  24. Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class

    著者: , , , , , , , , , , , , , , , , - Cell Reports 2021 被引用: 73